Kent Imaging Becomes Net Health’s First Integrated Imaging Device

First partner brings real-time decision-making for wound care plus innovative and non-invasive oxygenation imaging

Pittsburgh – January 26, 2021 – Tissue Analytics, a Net Health company that provides software solutions for the wound care industry, announced today that the company has partnered with Calgary, Canada-based Kent Imaging, Inc. to be the first member of its new application programming interface (APIs) program.  The API was announced in December, with additional partners scheduled to join in the coming months.

Kent Imaging is a leading innovator in oxygenation imaging that develops, manufactures, and markets medical technology that supports real-time decision making in wound care, vascular and surgical subspecialties.  Tissue Analytics is the market leader in wound imaging, providing artificial intelligence-powered software solutions that serve hospitals, post-acute facilities, and clinical trials.

The new agreement with Net Health enables Kent Imaging to expand the footprint and interoperability of their flagship product, SnapshotNIR®, which utilizes near-infrared light to determine tissue oxygen saturation (StO2), a key indicator of tissue health. Through the technology, clinicians are better able to plan appropriate interventions, reduce complications and improve outcomes.

“Our integration with Kent Imaging is the perfect example of the value of Net Health’s API,” said Kevin Keenahan, Senior Vice President of Business Development for Net Health and a founder of Tissue Analytics. “This agreement highlights how and why our API can benefit a wide range of industry innovators.”

Net Health’s API also enables vendors to benefit from the company’s downstream connections with leading wound care electronic health record (EHR) systems, including Net Health® Wound Care (formerly WoundExpert®), the most widely used wound care-specific EHR in the nation, as well as Cerner, Epic and others. 

“Kent Imaging is excited to work with Net Health through the Tissue Analytics API to ensure that critical information on the state of a wound is incorporated into the patient record at every visit,” said Pierre Lemire, CEO of Kent Imaging. “The integrated product streamlines workflow while providing documented tissue oxygenation data to complete the patient chart. By making our product interoperable with leading EMRs, we are ensuring that a wide range of clinicians and patients can access our innovative technology.”

Dr. Luc Marengere, Managing Partner, TVM Capital Life Science and member of the Board of Directors at Kent Imaging, also applauds the new partnership. “Collaborating with Net Health, a leader in the wound care market, will support the accelerated adoption of the SnapshotNIR technology,” says Marengere. “Clear unmet needs in wound care, such as non-healing wounds, are a huge burden with respect to patient outcome and ever-rising healthcare costs. Delivering innovative solutions through partnership provides synergy in responding positively to this growing concern.”

For more information, visit www.tissue-analytics.com and www.kentimaging.com.

About Net Health

Net Health provides software and analytics for specialty medical providers across the continuum of care. Net Health’s interoperable solutions ensure compliance, improve outcomes, empower providers and inspire care. The company serves over 14,000 facilities, including 98 percent of the largest hospital chains, two-thirds of skilled nursing facilities and many leading hospice organizations and private practices. Net Health is a portfolio company of The Carlyle Group, Level Equity and Silversmith Capital Partners. www.nethealth.com.

About Kent Imaging Inc.

Kent Imaging, located in Calgary, Alberta, Canada, is a leading innovator in oxygenation imaging, who develops, manufactures, and markets medical technology that supports real-time decision making in wound care, vascular and surgical subspecialties. Kent holds multiple patents in oxygen imaging technology and continues to provide innovative and advanced diagnostic imaging solutions to aid healthcare systems nationally and internationally. For more information about Kent Imaging, visit www.kentimaging.com.

PR Newswire Link  – https://www.prnewswire.com/news-releases/kent-imaging-becomes-net-healths-first-integrated-imaging-device-301214940.html

For more information:

Sandra Jenks, Kent Imaging sandra@kentimaging.com 403-455-7610

Kent Imaging Inc. Receives FDA 510(k) Clearance on SnapshotNIR V3.0

CALGARY, January 6, 2021 /EIN Presswire/ – Kent Imaging announced today the FDA 510(k) clearance for SnapshotNIR V3.0 (KD204) – now available for shipping. This upgrade provides significant feature enhancements to the imaging technology that advances tissue assessment in acute and chronic wounds. The multitude of advancements include the ability to image most skin tones (overcoming the melanin barrier), linear and surface area wound measurements, easy report generation with image comparisons, and enhanced patient file management, to name a few.

SnapshotNIR utilizes near infrared light to determine tissue oxygen saturation (StO2), which is a key indicator of tissue health. Ideal for microcirculation assessment, it conveys a comprehensive picture of the healing capacity of wounds or surgical tissue. This critical information is used to support clinical judgement in choosing, evaluating, and tracking treatment and surgical options throughout the care continuum.

“We are excited to release this enhanced version of SnapshotNIR as part of Kent’s dedication to bringing innovation to this critical market. Robust features asked for by front-line wound care specialists and reconstructive surgeons have been incorporated, delivering a product that can easily track and document wound healing progress and support therapeutic decisions,” noted Pierre Lemire, CEO. “SnapshotNIR V3.0 continues to support the goal of delivering on solutions that aid wound care and surgical specialists in improving patient outcomes and reducing complications.”

About Kent Imaging Inc.

Kent Imaging, located in Calgary, Alberta, Canada, is a leading innovator in oxygenation imaging, who develops, manufactures, and markets medical technology that supports real-time decision making in wound care, vascular and surgical sub-specialties. Kent holds multiple patents in oxygen imaging technology and continues to provide innovative and advanced diagnostic imaging solutions to aid healthcare systems nationally and internationally. For more information about Kent Imaging, visit www.kentimaging.com.

New and novel methods of non-invasive vascular assessment: enhancing triage protocols in wound healing and limb salvage

This CE/CME/CECH webinar presented by Dr. Richard Neville, MD (Director, Inova Vascular) and moderated by Dr. Lee Rogers, DPM (Chief Medical Officer at Amputation Prevention Experts (APEx) Health Network), is supported through an unrestricted educational grant from Kent Imaging. A recording of the webinar will reside on the podiatry.com website for 12 months following the live event. Register now for what is sure to be an intriguing topic in the management of critical limb ischemia.